Nuvalent Earnings Estimates, EPS & Revenue | NASDAQ:NUVL

Comments

Nuvalent Inc Earnings Estimates

NUVLNASDAQ

Trade with Public

$105.43

-0.21-0.20%

At close: Apr 2, 5:00 PM EST

$105.43

N/A

After Hours: Apr 2, 4:00 PM EST

Overview NewsEarningsOptions Analyst Ratings Insider Trades Short Interest Stock Report

Nuvalent Earnings Estimates, EPS & Revenue | NASDAQ:NUVL

Nuvalent (NUVL) is scheduled to report Q1 earnings on May 7, 2026. Analysts estimate EPS of $-1.32 and quarterly revenue of N/A.

In the most recent quarter (Q4), Nuvalent reported EPS of $-1.58, missing estimates of $-1.45 by 0.09%. Revenue came in at $0.00, meeting the estimate of $0.00 by 0.00%.

Nuvalent has missed EPS estimates in 4 consecutive quarters.

Over the last 4 quarters, Nuvalent has averaged an EPS surprise of 0.16% and a revenue surprise of 0.00%.

Earnings Date

May 7

EPS Estimate

$-1.320

Quarterly Revenue Estimate

–

Annual Revenue
(as of Dec 31)

–

Nuvalent Earnings History

Analyze the earnings history of Nuvalent using advanced sorting and filters.

Loading calendar...

Nuvalent (NUVL) Earnings Per Share

The chart below shows Nuvalent's reported EPS compared to analyst estimates over recent quarters.

Nuvalent (NUVL) Revenue

The chart below shows Nuvalent's reported revenue compared to analyst estimates over recent quarters.

FAQ

When is Nuvalent (NASDAQ:NUVL) reporting earnings?

Nuvalent (NUVL) is scheduled to report earnings on May 7, 2026. The last reported earnings were for reported on February 26, 2026 for Q4.

What were the latest earnings per share (EPS) for Nuvalent (NASDAQ:NUVL)?

The Actual EPS was $-1.58, which missed the estimate of $-1.45.

What were Nuvalent’s (NASDAQ:NUVL) revenues?

The Actual Revenue was $0.00, which hit the estimate of $0.00.

People Also Watch

Cogent Biosciences Inc

NASDAQ:COGT

$35.18

-0.09%

Neurocrine Biosciences Inc

NASDAQ:NBIX

$131.20

-0.30%

Centessa Pharmaceuticals PLC

NASDAQ:CNTA

$39.69

Ionis Pharmaceuticals Inc

Protagonist Therapeutics Inc

Nuvalent Earnings Estimates, EPS & Revenue | NASDAQ:NUVL

Nuvalent (NUVL) is scheduled to report Q1 earnings on May 7, 2026. Analysts estimate EPS of $-1.32 and quarterly revenue of N/A.

In the most recent quarter (Q4), Nuvalent reported EPS of $-1.58, missing estimates of $-1.45 by 0.09%. Revenue came in at $0.00, meeting the estimate of $0.00 by 0.00%.

Nuvalent has missed EPS estimates in 4 consecutive quarters.

Over the last 4 quarters, Nuvalent has averaged an EPS surprise of 0.16% and a revenue surprise of 0.00%.

Earnings Date

May 7

EPS Estimate

$-1.320

Quarterly Revenue Estimate

–

Annual Revenue
(as of Dec 31)

–